ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)

HKG:1541 Statistics

Total Valuation

HKG:1541 has a market cap or net worth of HKD 1.92 billion. The enterprise value is 1.05 billion.

Market Cap	1.92B
Enterprise Value	1.05B

Important Dates

The last earnings date was Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1541 has 431.51 million shares outstanding. The number of shares has increased by 9.35% in one year.

Current Share Class	420.48M
Shares Outstanding	431.51M
Shares Change (YoY)	+9.35%
Shares Change (QoQ)	+7.14%
Owned by Insiders (%)	16.32%
Owned by Institutions (%)	18.39%
Float	284.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.21
PB Ratio	2.19
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.30
EV / Sales	6.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.29.

Current Ratio	3.83
Quick Ratio	3.69
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.05

Financial Efficiency

Return on equity (ROE) is -29.87% and return on invested capital (ROIC) is -15.21%.

Return on Equity (ROE)	-29.87%
Return on Assets (ROA)	-13.80%
Return on Invested Capital (ROIC)	-15.21%
Return on Capital Employed (ROCE)	-27.11%
Weighted Average Cost of Capital (WACC)	8.66%
Revenue Per Employee	880,513
Profits Per Employee	-1.25M
Employee Count	195
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:1541 has paid 32,271 in taxes.

Income Tax	32,271
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.45% in the last 52 weeks. The beta is 0.97, so HKG:1541's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	-16.45%
50-Day Moving Average	4.70
200-Day Moving Average	8.85
Relative Strength Index (RSI)	46.72
Average Volume (20 Days)	2,114,320

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1541 had revenue of HKD 171.70 million and -243.24 million in losses. Loss per share was -0.59.

Revenue	171.70M
Gross Profit	170.46M
Operating Income	-248.20M
Pretax Income	-243.99M
Net Income	-243.24M
EBITDA	-236.76M
EBIT	-248.20M
Loss Per Share	-0.59

Balance Sheet

The company has 1.13 billion in cash and 253.75 million in debt, with a net cash position of 876.89 million or 2.03 per share.

Cash & Cash Equivalents	1.13B
Total Debt	253.75M
Net Cash	876.89M
Net Cash Per Share	2.03
Equity (Book Value)	879.27M
Book Value Per Share	2.11
Working Capital	869.26M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	11.64M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 99.28%, with operating and profit margins of -144.55% and -141.66%.

Gross Margin	99.28%
Operating Margin	-144.55%
Pretax Margin	-142.10%
Profit Margin	-141.66%
EBITDA Margin	-137.89%
EBIT Margin	-144.55%
FCF Margin	n/a

Dividends & Yields

HKG:1541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.35%
Shareholder Yield	-9.35%
Earnings Yield	-12.64%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1